ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,261.80
0.50%
S&P ASX All Technology
3,859.50
0.90%
Brent Oil
73.645
1.04%
US Dollar vs AUD
1.60853
0.09%
Bitcoin
94,545.80
-1.20%
Pepperstone
Advertisement
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. USOTC
  6. Bionik Laboratories Corporation (CE) (BNKL)

  7. Bionik Laboratories Corporation (CE) (BNKL) News

BNKL

Bionik Laboratories (CE) (BNKL)

Bionik Laboratories Corporation (CE)
Date:
Sort by:
 Showing the most relevant articles for your search:USOTC:BNKL
DateTimeSourceHeadlineSymbolCompany
01/07/202306:31Edgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]USOTC:BNKLBionik Laboratories Corporation (CE)
22/06/202307:05Edgar (US Regulatory)Annual Report (10-k)USOTC:BNKLBionik Laboratories Corporation (CE)
22/06/202300:59Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:BNKLBionik Laboratories Corporation (CE)
22/06/202300:58Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:BNKLBionik Laboratories Corporation (CE)
22/06/202300:58Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:BNKLBionik Laboratories Corporation (CE)
22/06/202300:56Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:BNKLBionik Laboratories Corporation (CE)
16/06/202322:56Edgar (US Regulatory)Current Report Filing (8-k)USOTC:BNKLBionik Laboratories Corporation (CE)
16/06/202303:10Edgar (US Regulatory)Current Report Filing (8-k)USOTC:BNKLBionik Laboratories Corporation (CE)
05/05/202307:25Edgar (US Regulatory)Current Report Filing (8-k)USOTC:BNKLBionik Laboratories Corporation (CE)
27/04/202306:31Edgar (US Regulatory)Current Report Filing (8-k)USOTC:BNKLBionik Laboratories Corporation (CE)
24/02/202308:08Edgar (US Regulatory)Current Report Filing (8-k)USOTC:BNKLBionik Laboratories Corporation (CE)
09/02/202308:21Edgar (US Regulatory)Current Report Filing (8-k)USOTC:BNKLBionik Laboratories Corporation (CE)
09/02/202300:02Edgar (US Regulatory)Quarterly Report (10-q)USOTC:BNKLBionik Laboratories Corporation (CE)
21/01/202308:32Edgar (US Regulatory)Current Report Filing (8-k)USOTC:BNKLBionik Laboratories Corporation (CE)
08/12/202203:29Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)USOTC:BNKLBionik Laboratories Corporation (CE)
08/12/202203:27Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)USOTC:BNKLBionik Laboratories Corporation (CE)
18/11/202209:26Edgar (US Regulatory)Current Report Filing (8-k)USOTC:BNKLBionik Laboratories Corporation (CE)
10/11/202200:01Edgar (US Regulatory)Quarterly Report (10-q)USOTC:BNKLBionik Laboratories Corporation (CE)
09/11/202223:31Edgar (US Regulatory)Current Report Filing (8-k)USOTC:BNKLBionik Laboratories Corporation (CE)
08/11/202200:02Edgar (US Regulatory)Current Report Filing (8-k)USOTC:BNKLBionik Laboratories Corporation (CE)
05/11/202207:32Edgar (US Regulatory)Amended Current Report Filing (8-k/a)USOTC:BNKLBionik Laboratories Corporation (CE)
26/10/202202:28Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)USOTC:BNKLBionik Laboratories Corporation (CE)
14/10/202204:18Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:BNKLBionik Laboratories Corporation (CE)
13/10/202223:01Edgar (US Regulatory)Current Report Filing (8-k)USOTC:BNKLBionik Laboratories Corporation (CE)
08/09/202221:32Edgar (US Regulatory)Current Report Filing (8-k)USOTC:BNKLBionik Laboratories Corporation (CE)
01/09/202221:31Edgar (US Regulatory)Current Report Filing (8-k)USOTC:BNKLBionik Laboratories Corporation (CE)
01/09/202206:31Edgar (US Regulatory)Current Report Filing (8-k)USOTC:BNKLBionik Laboratories Corporation (CE)
16/08/202221:35Edgar (US Regulatory)Current Report Filing (8-k)USOTC:BNKLBionik Laboratories Corporation (CE)
10/08/202222:03Edgar (US Regulatory)Quarterly Report (10-q)USOTC:BNKLBionik Laboratories Corporation (CE)
10/08/202221:31Edgar (US Regulatory)Current Report Filing (8-k)USOTC:BNKLBionik Laboratories Corporation (CE)
 Showing the most relevant articles for your search:USOTC:BNKL

Your Recent History

FX
GBPAUD
Sterling vs AUD
FX
AUDUSD
AUD vs US Dollar
NYSE
KO
Coca Cola
ASX
XTO
S&P ASX 100
NASDAQ
GOOGL
Alphabet
CCOM
SILVER
SILVER
ASX
RIO
Rio Tinto
ASX
WPL
Woodside Petroleum
NYSE
MCD
McDonalds
FX
EURAUD
Euro vs AUD
NYSE
MRK
Merck
COIN
ADAUSD
Cardano
ASX
BHP
BHP
ASX
WBC
Westpac Banking
ASX
XFL
S&P ASX 50
ASX
FMG
Fortescue
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads